These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 4068010
1. New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines. Janssens F, Torremans J, Janssen M, Stokbroekx RA, Luyckx M, Janssen PA. J Med Chem; 1985 Dec; 28(12):1925-33. PubMed ID: 4068010 [Abstract] [Full Text] [Related]
2. New antihistaminic N-heterocyclic 4-piperidinamines. 2. Synthesis and antihistaminic activity of 1-[(4-fluorophenyl)methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-a mines. Janssens F, Torremans J, Janssen M, Stokbroekx RA, Luyckx M, Janssen PA. J Med Chem; 1985 Dec; 28(12):1934-43. PubMed ID: 3934386 [Abstract] [Full Text] [Related]
3. New antihistaminic N-heterocyclic 4-piperidinamines. 3. Synthesis and antihistaminic activity of N-(4-piperidinyl)-3H-imidazo[4,5-b]pyridin-2-amines. Janssens F, Torremans J, Janssen M, Stokbroekx RA, Luyckx M, Janssen PA. J Med Chem; 1985 Dec; 28(12):1943-7. PubMed ID: 3934387 [Abstract] [Full Text] [Related]
4. Synthesis and structure-activity relationships of a new series of benzimidazoles as H1-antihistaminic agents. Cuberes MR, Contijoch M, Calvet C, Alegre J, Quintana JR, Frigola J. Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1287-92. PubMed ID: 9301027 [Abstract] [Full Text] [Related]
5. 4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds. Freter K, Fuchs V, Barsumian E, Oliver JT. Arzneimittelforschung; 1985 Aug; 35(1A):272-6. PubMed ID: 2580540 [Abstract] [Full Text] [Related]
6. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions. Gutiérrez B, Dordal A, Fort M, Galicia J, Farré AJ. Methods Find Exp Clin Pharmacol; 1996 Aug; 18(6):397-406. PubMed ID: 8892269 [Abstract] [Full Text] [Related]
7. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A. Drugs R D; 2006 Aug; 7(4):219-31. PubMed ID: 16784247 [Abstract] [Full Text] [Related]
8. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents. Iemura R, Kawashima T, Fukuda T, Ito K, Tsukamoto G. J Med Chem; 1986 Jul; 29(7):1178-83. PubMed ID: 2879912 [Abstract] [Full Text] [Related]
9. The role of HB-donor groups in the heterocyclic polar fragment of H3-antagonists. I. Synthesis and biological assays. Zuliani V, Bordi F, Rivara M, Silva C, Vacondio F, Morini G, Rivara S, Barocelli E, Ballabeni V, Bertoni S, Magnanini F, Plazzi PV. Farmaco; 2003 Sep; 58(9):891-9. PubMed ID: 13679184 [Abstract] [Full Text] [Related]
10. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the alkyl derivatives. Lazewska D, Kieć-Kononowicz K, Elz S, Pertz HH, Stark H, Schunack W. Pharmazie; 2005 Jun; 60(6):403-10. PubMed ID: 15997826 [Abstract] [Full Text] [Related]
11. Piperidino-hydrocarbon compounds as novel non-imidazole histamine H(3)-receptor antagonists. Meier G, Ligneau X, Pertz HH, Ganellin CR, Schwartz JC, Schunack W, Stark H. Bioorg Med Chem; 2002 Aug; 10(8):2535-42. PubMed ID: 12057642 [Abstract] [Full Text] [Related]
12. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds. Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. J Med Chem; 2003 Apr 10; 46(8):1523-30. PubMed ID: 12672253 [Abstract] [Full Text] [Related]
13. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators. Fukuda T, Morimoto Y, Iemura R, Kawashima T, Tsukamoto G, Ito K. Arzneimittelforschung; 1984 Apr 10; 34(7):801-5. PubMed ID: 6149754 [Abstract] [Full Text] [Related]
14. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine. Carceller E, Merlos M, Giral M, Balsa D, Almansa C, Bartrolí J, García-Rafanell J, Forn J. J Med Chem; 1994 Aug 19; 37(17):2697-703. PubMed ID: 7914928 [Abstract] [Full Text] [Related]
15. [Pyrrolidone and piperidone derivatives with antihistaminic and antianaphylactic activities. Synthesis and pharmacological study]. de Meglio PG, Corradi F, Ravenna F, Gentili P, Tempra-Gabbiati G, Cristina T, Riva M. Farmaco Sci; 1987 May 19; 42(5):359-82. PubMed ID: 3609293 [Abstract] [Full Text] [Related]
16. Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length. Łazewska D, Kieć-Kononowicz K, Pertz HH, Stark H, Schunack W, Elz S. Pharmazie; 2001 Dec 19; 56(12):927-32. PubMed ID: 11802653 [Abstract] [Full Text] [Related]
17. Syntheses of the metabolites of 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H benzimidazole difumarate (KG-2413) and related compounds. Iemura R, Hori M, Ohtaka H. Chem Pharm Bull (Tokyo); 1989 Apr 19; 37(4):962-6. PubMed ID: 2569942 [Abstract] [Full Text] [Related]
18. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality. Łazewska D, Kieć-Kononowicz K, Pertz HH, Elz S, Stark H, Schunack W. Pharmazie; 2002 Dec 19; 57(12):791-5. PubMed ID: 12561236 [Abstract] [Full Text] [Related]
19. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity. Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A. Drugs R D; 2005 Dec 19; 6(6):371-84. PubMed ID: 16274260 [Abstract] [Full Text] [Related]
20. [Synthesis and spectrum of pharmacologic action of aryl-arylamino- and aryl-aryliminoacetonitriles]. Barnikow G, Hagen A, Hagen V, Göres E, Richter D, Fichtner K. Pharmazie; 1983 Jul 19; 38(7):449-52. PubMed ID: 6634911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]